NCT01117987 Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE3
NCT01105117 Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 Status COMPLETED Phase PHASE4
NCT01105091 Epoprostenol for Injection in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT01100736 Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3) Status COMPLETED Phase EARLY_PHASE1
NCT01094067 Tezosentan in Patients With Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE2
NCT01092559 Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide Status COMPLETED Phase PHASE2
NCT01066845 Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT01054105 Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT01043627 Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Status COMPLETED Phase N/A
NCT01042158 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Status COMPLETED Phase PHASE4
NCT01028651 A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Status COMPLETED Phase N/A
NCT01027949 An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT00995566 A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin Status TERMINATED Phase N/A
NCT00993408 Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE2
NCT00990314 Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients Status COMPLETED Phase PHASE2
NCT00989963 Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE2
NCT00964678 Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE1/PHASE2